CIK 0001907108 · <br>Emerging growth company
Lexeo Therapeutics, Inc.
Sign in to watch- Ticker
- LXEO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 854012572
- Phone
- (212) 547-9879
- Business address
- 345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,228
- in 3 filings
Net −$43,228. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-11 | Townsend Richard Nolan Chief Executive Officer | Sale 10b5-1 | −100 | $19.06 | $2K | 120,695 |
| 2024-07-10 | Townsend Richard Nolan Chief Executive Officer | Option exercise 10b5-1 | +5,000 | $2.33 | $12K | 175,695 |
| 2024-07-10 | Townsend Richard Nolan Chief Executive Officer | Sale 10b5-1 | −23,622 | $16.45 | $389K | 152,073 |
| 2024-07-10 | Townsend Richard Nolan Chief Executive Officer | Sale 10b5-1 | −3,347 | $16.85 | $56K | 148,726 |
| 2024-07-10 | Townsend Richard Nolan Chief Executive Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 138,655 | ||
| 2024-07-05 | Van Hauwermeiren Timothy Director | Grant or award · Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2024-06-25 | COOPERSTONE BRENDA Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2024-06-25 | Altschuler Steven Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2024-06-25 | DIAZ REINALDO M Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2024-06-25 | CHOLMONDELEY PAULA H Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2024-06-25 | Agger Mette Kirstine Director | Grant or award · Stock Option (right to buy) | +18,000 | 18,000 | ||
| 2024-06-12 | Otero Jose Manuel Chief Technical Officer | Grant or award 10b5-1 | +31,250 | 31,250 | ||
| 2024-06-12 | Otero Jose Manuel Chief Technical Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +187,500 | 187,500 | ||
| 2024-06-10 | Townsend Richard Nolan Chief Executive Officer | Option exercise 10b5-1 | +5,000 | $2.33 | $12K | 175,695 |
| 2024-06-10 | Townsend Richard Nolan Chief Executive Officer | Sale 10b5-1 | −2,962 | $17.29 | $51K | 172,733 |
| 2024-06-10 | Townsend Richard Nolan Chief Executive Officer | Sale 10b5-1 | −2,038 | $18.18 | $37K | 170,695 |
| 2024-06-10 | Townsend Richard Nolan Chief Executive Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −5,000 | 143,655 | ||
| 2024-05-13 | Townsend Richard Nolan Chief Executive Officer | Option exercise 10b5-1 | +5,000 | $2.33 | $12K | 175,695 |
| 2024-05-13 | Townsend Richard Nolan Chief Executive Officer | Sale 10b5-1 | −5,000 | $13.22 | $66K | 170,695 |
| 2024-05-13 | Townsend Richard Nolan Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | $2.33 | $12K | 148,655 |
Page 7 of 9 · 165 trades